VMP 42185911000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Brimonidine 0.2% eye drops
BNF code 1106000AAAAAAAA
Virtual Therapeutic Moiety Brimonidine
Date identifier became valid 25 Aug 2023
Previous product identifier 330731001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Continuous
Virtual Product Ingredient
Ingredient Brimonidine tartrate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 2.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutiondrops.ophthalmic
Dose Form
Formulation Eye drops
Drug Route
Route Ocular
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Alphagan 0.2% eye drops (AbbVie Ltd)
Alphagan 0.2% eye drops (CST Pharma Ltd)
Alphagan 0.2% eye drops (Lexon (UK) Ltd)
Alphagan 0.2% eye drops (Sigma Pharmaceuticals Plc)
Brimonidine 0.2% eye drops (A A H Pharmaceuticals Ltd)
Brimonidine 0.2% eye drops (Alliance Healthcare (Distribution) Ltd)
Brimonidine 0.2% eye drops (Blumont Pharma Ltd)
Brimonidine 0.2% eye drops (FDC International Ltd)
Brimonidine 0.2% eye drops (Medihealth (Northern) Ltd)
Brimonidine 0.2% eye drops (Phoenix Healthcare Distribution Ltd)
Brimonidine 0.2% eye drops (Sigma Pharmaceuticals Plc)
Brimonidine 2mg/ml eye drops (Brown & Burk UK Ltd)
Brimonidine 2mg/ml eye drops (Medicom Healthcare Ltd)
Virtual Medicinal Product Packs
Brimonidine 0.2% eye drops 5 ml

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback